Healthy Person Clinical Trial
Official title:
A Randomized, Double-blind, Placebo-controlled, Dose-escalating, Single-dose, Oral Phase I Clinical Study of the Safety, Tolerability, and Pharmacokinetics of Flunotinib Maleate Tablets in Healthy Adult Subjects in China.
Evaluate the safety and tolerability of a single increasing dose of Flibanserin Maleate tablets administered orally to healthy adult Chinese subjects; preliminarily assess the pharmacokinetic characteristics of a single dose of oral Flibanserin Maleate tablets
The goal of this clinical trial is to evaluate the safety of sflunotinib maleate tablets. The main question[s] it aims to answer are: 1. The safety and tolerability of single oral doses of flunotinib maleate tablets in escalating doses in healthy adult subjects in China 2. The pharmacokinetic characteristics of a single dose of oral flunotinib maleate tablets Participants will divide into experimental group and placebo group, conduct single oral administration safety and tolerability test group by group ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06432738 -
ZL-82 Double-blind Clinical Trial
|
Phase 1 | |
| Recruiting |
NCT05693233 -
Effect of Soft Robotic Exosuit Assistance in Healthy People
|
N/A | |
| Completed |
NCT01745835 -
Comparison Between 2L Coolprep® and Combination of 1L Coolprep® and Bisacodyl as Bowel Preparation
|
Phase 3 | |
| Terminated |
NCT03775473 -
PROgastrine COlon DEpistage
|
N/A | |
| Completed |
NCT05316857 -
DDI Study of Orelabrutinib
|
Phase 1 | |
| Completed |
NCT06213792 -
Visuo-Vestibular Adaptation in Virtual Reality
|